サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1382599

欧州の核酸サンプル調製市場の分析・予測：2022-2032年

Europe Nucleic Acid Sample Preparation Market - Analysis and Forecast, 2022-2032
出版日: | 発行: BIS Research | ページ情報: 英文 107 Pages | 納期: 1～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
欧州の核酸サンプル調製市場の分析・予測：2022-2032年
出版日: 2023年11月17日
発行: BIS Research
ページ情報: 英文 107 Pages
納期: 1～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の核酸サンプル調製の市場規模は、2022年の13億740万米ドルから、予測期間中は9.89%のCAGRで推移し、2032年には33億5,670万米ドルの規模に成長すると予測されています。

核酸分子のさまざまな医療分野での使用機会の増加が、欧州の核酸サンプル調製市場の成長に拍車をかけると予想されています。さらに、同地域の核酸サンプル調製市場は、次世代シーケンシング (NGS) などの下流用途の需要の増加や、核酸抽出/分離技術に関連するその他の発展が大きな要因となって拡大しています。

また、迅速な診断情報と的を絞った患者治療に対する需要の高まりも同市場の成長を推進しています。このニーズに対応するため、自動核酸サンプル調製ワークステーションを含むさまざまな分子手順が開発されています。さらに、サンプル調製は精密医療において重要な役割を果たしており、個別化治療の確実かつ効果的な適用を保証しています。

当レポートでは、欧州の核酸サンプル調製の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業の分析などをまとめています。

主要市場統計
予測期間 2022-2032年
2022年評価 13億740万米ドル
2032年予測 33億5,670万米ドル
CAGR 9.89%

市場セグメンテーション

セグメンテーション1：国別

  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • 英国
  • その他の欧州

目次

第1章 市場

  • 製品の定義
  • 市場範囲
  • 調査手法
  • 市場概要
    • 市場の定義
    • 市場規模・成長の可能性
  • 対応可能な市場規模・成長の可能性
    • 欧州
  • 参入事業者の情勢

第2章 核酸サンプル調製市場：業界分析

  • 業界考察
    • 欧州の法的要件と枠組み
  • 特許分析
  • COVID-19による核酸サンプル調製市場への影響

第3章 核酸サンプル調製市場：市場力学

  • 概要
  • 市場促進要因
    • さまざまな治療分野における核酸分子の使用の増加
    • 核酸抽出・単離技術の進歩
    • 自動サンプル調製ワークステーションの利点
    • 次世代シーケンシング (NGS) などの下流用途の需要の増加
  • 市場抑制要因
    • 自動ワークステーションの高コスト性
    • 厳格な規制基準
  • 市場機会
    • 自動サンプル調製ワークステーションにおける技術の進歩
    • バイオバンキングのための核酸分子
    • 新興国の成長

第4章 競合情勢

  • 概要
  • 企業戦略
  • 事業戦略
  • 市場シェア分析

第5章 核酸サンプル調製市場：地域別

  • 概要
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • 欧州のその他の地域

第6章 企業プロファイル

  • Endress+Hauser Group Services AG (Analytik Jena GmbH)
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • QIAGEN
  • Tecan Trading AG
図表

List of Figures

  • Figure 1: Nucleic Acid Sample Preparation Market, $Million, 2021 and 2032
  • Figure 2: Nucleic Acid Sample Preparation Market Segmentation
  • Figure 3: Share of Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
  • Figure 4: Share of Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
  • Figure 5: Share of Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
  • Figure 6: Share of Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
  • Figure 7: Share of Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
  • Figure 8: Share of Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
  • Figure 9: Nucleic Acid Sample Preparation Market (by Region)
  • Figure 10: Nucleic Acid Sample Preparation Market Segmentation
  • Figure 11: Nucleic Acid Sample Preparation Market: Research Methodology
  • Figure 12: Primary Research Methodology
  • Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 14: Top-Down Approach (Segment-Wise Analysis)
  • Figure 15: Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 16: Europe Nucleic Acid Sample Preparation Addressable Market, 2021-2032
  • Figure 17: Nucleic Acid Sample Preparation Market, Patent Analysis (by Year), January 2019-December 2022
  • Figure 18: Nucleic Acid Sample Preparation Market, Patent Analysis (by Country), January 2019-December 2022
  • Figure 19: Nucleic Acid Sample Preparation Market, Patent Analysis (by Region), January 2019-December 2022
  • Figure 20: Virus Testing Workflow
  • Figure 21: NGS Applications in Laboratories during COVID-19
  • Figure 22: Nucleic Acid Sample Preparation Market - Market Dynamics
  • Figure 23: Techniques for Nucleic Acid Extraction/Isolation
  • Figure 24: Benefits of Automated Nucleic Acid Sample Preparation
  • Figure 25: Share of Key Developments, January 2019-November 2022
  • Figure 26: Share of Synergistic Activities (by Company), January 2019-November 2022
  • Figure 27: Number of Business Expansion Activities (by Company), January 2019-November 2022
  • Figure 28: Number of Product Launches (by Company), January 2019-November 2022
  • Figure 29: Market Share Analysis of the Global Nucleic Acid Sample Preparation Market (by Company), 2021
  • Figure 30: Nucleic Acid Sample Preparation Market (by Region)
  • Figure 31: Nucleic Acid Sample Preparation Market (by Region), $Million, 2021-2032
  • Figure 32: Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 33: Europe Nucleic Acid Sample Preparation Market (by Country), 2021 and 2032
  • Figure 34: Germany Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 35: France Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 36: U.K. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 37: Italy Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 38: Spain Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 39: Rest-of-Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 40: Total Number of Companies Profiled
  • Figure 41: Endress+Hauser Group Services AG (Analytik Jena GmbH): Product Portfolio
  • Figure 42: Endress+Hauser Group Services AG (Analytik Jena GmbH): Overall Financials, $Million, 2019-2021
  • Figure 43: Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Segment), $Million, 2019-2021
  • Figure 44: Endress+Hauser Group Services AG (Analytik Jena GmbH): R&D Expenditure, $Million, 2019-2021
  • Figure 45: Eppendorf SE: Product Portfolio
  • Figure 46: Eppendorf SE: Overall Financials, $Million, 2019-2021
  • Figure 47: Eppendorf SE: Revenue (by Segment), $Million, 2019-2021
  • Figure 48: Eppendorf SE: Revenue (by Region), $Million, 2019-2021
  • Figure 49: Eppendorf SE: R&D Expenditure, $Million, 2019-2021
  • Figure 50: F. Hoffmann-La Roche Ltd: Product Portfolio
  • Figure 51: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021
  • Figure 52: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021
  • Figure 53: F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021
  • Figure 54: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021
  • Figure 55: Merck KGaA: Product Portfolio
  • Figure 56: Merck KGaA: Overall Financials, $Million, 2019-2021
  • Figure 57: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
  • Figure 58: Merck KGaA: Revenue (by Region), $Million, 2019-2021
  • Figure 59: Merck KGaA: R&D Expenditure, $Million, 2019-2021
  • Figure 60: QIAGEN: Product Portfolio
  • Figure 61: QIAGEN: Overall Financials, 2019-2021
  • Figure 62: QIAGEN: Revenue (by Segment), 2019-2021
  • Figure 63: QIAGEN: Revenue (by Region), 2019-2021
  • Figure 64: QIAGEN: R&D Expenditure, 2019-2021
  • Figure 65: Tecan Trading AG: Product Portfolio
  • Figure 66: Tecan Trading AG: Overall Financials, 2019-2021
  • Figure 67: Tecan Trading AG: Revenue (by Segment), 2019-2021
  • Figure 68: Tecan Trading AG: Revenue (by Region), 2019-2021
  • Figure 69: Tecan Trading AG: R&D Expenditure, 2019-2021

List of Tables

  • Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Nucleic Acid Sample Preparation Market
  • Table 2: Industry Participants' Landscape in the Nucleic Acid Sample Preparation Market
  • Table 3: Cost of Automated Workstations
目次
Product Code: BHP1512SS

“The Europe Nucleic Acid Sample Preparation Market Expected to Reach $3,356.7 Million by 2032.”

Introduction to Europe Nucleic Acid Sample Preparation Market

The Europe nucleic acid sample preparation market is projected to reach $3,356.7 million by 2032 from $1,307.4 million in 2022, growing at a CAGR of 9.89% during the forecast period 2022-2032. The increased use of nucleic acid molecules in a variety of medicinal contexts is expected to fuel the growth of the nucleic acid sample preparation market in Europe. Furthermore, the region's nucleic acid sample preparation market is expanding due in large part to the increased demand for downstream applications such as next-generation sequencing (NGS) and other associated developments in nucleic acid extraction/isolation techniques.

KEY MARKET STATISTICS
Forecast Period2022 - 2032
2022 Evaluation$1,307.4 Million
2032 Forecast$3,356.7 Million
CAGR9.89%

Market Introduction

The nucleic acid sample preparation market in Europe is currently advancing to meet the increasing demand for prompt diagnostic information and targeted patient treatment. Various molecular procedures, including automated nucleic acid sample preparation workstations, have been developed to address this need. Furthermore, sample preparation plays a crucial role in precision medicine, ensuring the secure and effective application of personalized therapies. The market provides a diverse range of universal products with varying maximum throughputs, innovations, time durations, and other attributes, prompting companies to explore inventive ways to differentiate themselves. Notably, manufacturers have recently introduced application-specific nucleic acid purification devices and liquid handlers to cater to specific needs in the European market.

Impact

One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.

Market Segmentation:

Segmentation 1: by Country

  • Germany
  • France
  • Italy
  • Spain
  • U.K.
  • Rest-of-Europe

In 2021, Europe accounted for a share of 31.14% of the nucleic acid sample preparation market. The presence of some of the prominent companies in the market is a key factor driving the growth of the Europe region.

Recent Developments in the Europe Nucleic Acid Sample Preparation Market

  • In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan's 96-well filter plates for use in RevoluGen's automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.

How can this report add value to an organization?

Growth/Marketing Strategy: Nucleic acid sample preparation is being used for genomics, proteomics, and other applications. Various companies are providing consumables and systems aid in the diagnosis of various therapeutic areas, which is also the key strategy for market players to excel in the current Europe nucleic acid sample preparation market.

Competitive Strategy: Key players in the Europe nucleic acid sample preparation market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe nucleic acid sample preparation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

  • Endress+Hauser Group Services AG
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • QIAGEN
  • Tecan Trading AG

Table of Contents

1 Market

  • 1.1 Product Definition
    • 1.1.1 Inclusion and Exclusion Criteria
  • 1.2 Market Scope
    • 1.2.1 Scope of the Study
    • 1.2.2 Key Questions Answered in the Report
  • 1.3 Research Methodology
    • 1.3.1 Nucleic Acid Sample Preparation Market: Research Methodology
    • 1.3.2 Data Sources
      • 1.3.2.1 Primary Data Sources
      • 1.3.2.2 Secondary Data Sources
    • 1.3.3 Market Estimation Model
    • 1.3.4 Criteria for Company Profiling
  • 1.4 Market Overview
    • 1.4.1 Market Definition
    • 1.4.2 Market Footprint and Growth Potential, $Million, 2021-2032
  • 1.5 Addressable Market Size and Growth Potential ($Million), 2021-2032
    • 1.5.1 Europe
  • 1.6 Industry Participants Landscape

2 Nucleic Acid Sample Preparation Market, Industry Analysis

  • 2.1 Industry Insights
    • 2.1.1 Legal Requirements and Framework in Europe
  • 2.2 Patent Analysis
    • 2.2.1 Patent Filing Trend
    • 2.2.2 Patent Analysis (by Year)
    • 2.2.3 Patent Analysis (by Country)
    • 2.2.4 Patent Analysis (by Region)
  • 2.3 Impact of COVID-19 on the Nucleic Acid Sample Preparation Market

3 Nucleic Acid Sample Preparation Market: Market Dynamics

  • 3.1 Overview
  • 3.2 Market Drivers
    • 3.2.1 Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
    • 3.2.2 Advancement in the Nucleic Acid Extraction/Isolation Techniques
    • 3.2.3 Advantages of Automated Sample Preparation Workstations
    • 3.2.4 Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
  • 3.3 Market Restraints
    • 3.3.1 High Cost of Automated Workstations
    • 3.3.2 Rigid Regulatory Standards
  • 3.4 Market Opportunities
    • 3.4.1 Technological Advancements in Automated Sample Preparation Workstations
    • 3.4.2 Nucleic Acid Molecules for Biobanking in Healthcare
    • 3.4.3 Growth in Emerging Nations

4 Competitive Landscape

  • 4.1 Overview
  • 4.2 Corporate Strategies
    • 4.2.1 Mergers and Acquisitions
    • 4.2.2 Synergistic Activities
    • 4.2.3 Business Expansions
  • 4.3 Business Strategies
    • 4.3.1 Product Launches
  • 4.4 Market Share Analysis

5 Nucleic Acid Sample Preparation Market, by Region ($Million), 2021-2032

  • 5.1 Overview
  • 5.2 Europe
    • 5.2.1 Germany
    • 5.2.2 France
    • 5.2.3 U.K.
    • 5.2.4 Italy
    • 5.2.5 Spain
    • 5.2.6 Rest-of-Europe

6 Company Profiles

  • 6.1 Overview
  • 6.2 Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • 6.2.1 Company Overview
    • 6.2.2 Role of Endress+Hauser Group Services AG (Analytik Jena GmbH) in the Global Nucleic Acid Sample Preparation Market
    • 6.2.3 Key Customers of the Company
    • 6.2.4 Key Competitors of the Company
    • 6.2.5 Business Strategies
    • 6.2.6 Financials
    • 6.2.7 Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Region), $Million, 2019-2021
    • 6.2.8 Key Insights about the Financial Health of the Company
    • 6.2.9 Analyst Perspective
  • 6.3 Eppendorf SE
    • 6.3.1 Company Overview
    • 6.3.2 Role of Eppendorf SE in the Nucleic Acid Sample Preparation Market
    • 6.3.3 Key Competitors of the Company
    • 6.3.4 Financials
    • 6.3.5 Key Insights about the Financial Health of the Company
    • 6.3.6 Analyst Perspective
  • 6.4 F. Hoffmann-La Roche Ltd
    • 6.4.1 Company Overview
    • 6.4.2 Role of F. Hoffmann-La Roche Ltd in the Nucleic Acid Sample Preparation Market
    • 6.4.3 Key Competitors of the Company
    • 6.4.4 Business Strategies
    • 6.4.5 Financials
    • 6.4.6 Key Insights about the Financial Health of the Company
    • 6.4.7 Analyst Perspective
  • 6.5 Merck KGaA
    • 6.5.1 Company Overview
    • 6.5.2 Role of Merck KGaA in the Nucleic Acid Sample Preparation Market
    • 6.5.3 Key Competitors of the Company
    • 6.5.4 Financials
    • 6.5.5 Key Insights about the Financial Health of the Company
    • 6.5.6 Analyst Perspective
  • 6.6 QIAGEN
    • 6.6.1 Company Overview
    • 6.6.2 Role of QIAGEN in the Nucleic Acid Sample Preparation Market
    • 6.6.3 Key Customers of the Company
    • 6.6.4 Key Competitors of the Company
    • 6.6.5 Business Strategies
    • 6.6.6 Financials
    • 6.6.7 Key Insights about the Financial Health of the Company
    • 6.6.8 Analyst Perspective
  • 6.7 Tecan Trading AG
    • 6.7.1 Company Overview
    • 6.7.2 Role of Tecan Trading AG in the Nucleic Acid Sample Preparation Market
    • 6.7.3 Key Customers of the Company
    • 6.7.4 Key Competitors of the Company
    • 6.7.5 Financials
    • 6.7.6 Key Insights about the Financial Health of the Company
    • 6.7.7 Analyst Perspective